Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays

被引:1
作者
Nguyen, Huong Thi [1 ]
Hurh, Sunghoon [1 ]
Nguyen, Lan Phuong [1 ]
Nguyen, Thai Uy [1 ]
Park, Hee-Kyung [1 ]
Seong, Jae Young [1 ]
Lee, Cheol Soon [1 ]
Ham, Byung-Joo [1 ,2 ]
Hwang, Jong-Ik [1 ]
机构
[1] Korea Univ, Coll Med, Dept Biomed Sci, Seoul 02841, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Seoul 02841, South Korea
关键词
chemotaxis; CXCR3; IP-10; I-TAC; MIG; NanoBiT technology; PROTEIN-COUPLED RECEPTOR; CHEMOKINE RECEPTORS; PROMOTES INVASION; I-TAC; CELLS; EXPRESSION; DIMERIZATION; METASTASIS; ACTIVATION; RELEASE;
D O I
10.14348/molcells.2023.2096
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CXCR3 regulates leukocyte trafficking, maturation, and various pathophysiological conditions. Alternative splicing generates three CXCR3 isoforms in humans. Previous studies investigated the roles of CXCR3 isoforms, and some biochemical data are not correlated with biological relevance analyses. RT-PCR analyses indicate that most cells express all three splicing variants, suggesting that they may mutually affect the chemokine binding and cellular responses of other splicing variants. Here, we performed an integrative analysis of the functional relations among CXCR3 splicing variants and their chemokine-dependent signaling using NanoBiT live cell protein interaction assays. The results indicated that the CXCR3 N-terminal region affected cell surface expression levels and ligand-dependent activation. CXCR3A was efficiently expressed in the plasma membrane and responded to I-TAC, IP-10, and MIG chemokines. By contrast, CXCR3B had low plasma membrane expression and mediated I-TAC-stimulated cellular responses. CXCR3Alt was rarely expressed on the cell surface and did not mediate any cell responses to the tested chemokines; however, CXCR3Alt negatively affected the plasma membrane expression of CXCR3A and CXCR3B and their chemokine-stimulated cellular responses. Jurkat cells express endogenous CXCR3, and exogenous CXCR3A expression enhanced chemotactic activity in response to I-TAC, IP-10, and MIG. By contrast, exogenous expression of CXCR3B and CXCR3Alt eliminated or reduced the CXCR3A-induced chemotactic activity. The PF-4 chemokine did not activate any CXCR3-mediated cellular responses. NanoBiT technology are useful to integrative studies of CXCR3-mediated cell signaling, and expand our knowledge of the cellular responses mediated by molecular interactions among the splicing variants, including cell surface expression, ligand-dependent receptor activation, and chemotaxis.
引用
收藏
页码:281 / 297
页数:17
相关论文
共 51 条
[1]   CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways [J].
Berchiche, Yamina A. ;
Sakmar, Thomas P. .
MOLECULAR PHARMACOLOGY, 2016, 90 (04) :483-495
[2]   Chemokine Regulation of Angiogenesis During Wound Healing [J].
Bodnar, Richard J. .
ADVANCES IN WOUND CARE, 2015, 4 (11) :641-650
[3]  
Cheng Zhijie, 2010, Curr Chem Genomics, V4, P84, DOI 10.2174/1875397301004010084
[4]   Structure-function relationship between the human chemokine receptor CXCR3 and its ligands [J].
Clark-Lewis, I ;
Mattioli, I ;
Gong, JH ;
Loetscher, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :289-295
[5]   Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021
[6]   Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping [J].
Ehlert, JE ;
Addison, CA ;
Burdick, MD ;
Kunkel, SL ;
Strieter, RM .
JOURNAL OF IMMUNOLOGY, 2004, 173 (10) :6234-6240
[7]  
EISMAN R, 1990, BLOOD, V76, P336
[8]   Mig and IP-10: CXC chemokines that target lymphocytes [J].
Farber, JM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (03) :246-257
[9]  
FILES JC, 1981, BLOOD, V58, P607
[10]   Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells [J].
Fleischer, J ;
Grage-Griebenow, E ;
Kasper, B ;
Heine, H ;
Ernst, M ;
Brandt, E ;
Flad, HD ;
Petersen, F .
JOURNAL OF IMMUNOLOGY, 2002, 169 (02) :770-777